|
Elabscience Biotechnology
sstr3 ![]() Sstr3, supplied by Elabscience Biotechnology, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/sstr3/product/Elabscience Biotechnology Average 93 stars, based on 1 article reviews
sstr3 - by Bioz Stars,
2026-06
93/100 stars
|
Buy from Supplier |
|
OriGene
reagent sst reverse primer mgh ![]() Reagent Sst Reverse Primer Mgh, supplied by OriGene, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/reagent sst reverse primer mgh/product/OriGene Average 96 stars, based on 1 article reviews
reagent sst reverse primer mgh - by Bioz Stars,
2026-06
96/100 stars
|
Buy from Supplier |
|
Santa Cruz Biotechnology
sstr2 ![]() Sstr2, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/sstr2/product/Santa Cruz Biotechnology Average 93 stars, based on 1 article reviews
sstr2 - by Bioz Stars,
2026-06
93/100 stars
|
Buy from Supplier |
Image Search Results
Journal: The EMBO Journal
Article Title: Somatostatin triggers local cAMP and Ca 2+ signaling in primary cilia to modulate pancreatic β-cell function
doi: 10.1038/s44318-025-00383-7
Figure Lengend Snippet: ( A ) Confocal microscopy images showing ciliary localization of SSTR3 (green) in both insulin-positive and -negative cells in a human islet. ( B ) Confocal microscopy images from a mouse islet (top) and MIN6 pseudoislet (bottom) showing the localization of SSTR3 to primary cilia (visualized by anti-acetylated tubulin immunostaining and shown in magenta). ( C ) Quantifications of the effect of 18 h somatostatin treatment (100 nM) on cilia length (determined as AUC for normalized acetylated tubulin immunoreactivity) in MIN6 cells (means ± SEM; nctrl = 111, nSST = 87 cilia from three different preparations, change in cilia length P = 0.003 assessed by unpaired Kolmogorov–Smirnov test). ( D ) Quantifications of the effect of 18 h ( G ) and 15 min ( H ) somatostatin treatment on cilia SSTR3 immunoreactivity in MIN6 pseudoislets (means ± SEM; for 18 h SST treatments; n ctrl = 111, n SST = 87 cilia from three different preparations, change in SSTR3 not significant; for 15 min SST treatment n ctrl = 340, n SST = 295 cilia from three different preparations, P = 0.0146. Significance is assessed by unpaired Kolmogorov–Smirnov test). ( E ) Quantification of fraction of SSTR3-positive cilia in MIN6 cells exposed to 100 nM somatostatin for 18 h (means ± SEM; n ctrl = 111, n SST = 87 cilia from three different preparations). ( F ) STED microscopy images showing the distribution of SSTR3 (magenta) in mouse islet cells under resting condition and after 15 min SST stimulation. ( G – I ) Quantifications of the effect of 18 h somatostatin treatment on cilia length ( G ), cilia SSTR3 immunoreactivity ( H ) and fraction of SSTR3-positive cilia ( I ) in mouse islet cells (means ± SEM; n ctrl = 170, n SST = 171 cilia from two different animals, P AcT = 0.0055, P SSTR3 = 0.0030, assessed by unpaired Kolmogorov–Smirnov test).
Article Snippet: The following primary antibodies were used in the study; acetylated tubulin (T745, host: mouse, 1:500; Sigma-Aldrich), Acetyl-α-Tubulin (K40) (5335, host: rabbit, 1:500; BioNordika),
Techniques: Confocal Microscopy, Immunostaining, Microscopy
Journal: The EMBO Journal
Article Title: Somatostatin triggers local cAMP and Ca 2+ signaling in primary cilia to modulate pancreatic β-cell function
doi: 10.1038/s44318-025-00383-7
Figure Lengend Snippet: ( A ) Confocal microscopy images of human islets from a non-diabetic and a type-2 diabetic (T2D) organ donor immunostained against insulin (cyan) and acetylated tubulin (magenta) (white arrowheads point to cilia). ( B ) Quantifications of cilia length in insulin-positive and negative cells of non-diabetic and type-2 diabetic islets (means ± SD; ND: N = 7 donors; 10–20 islets per donor; 946 cilia. T2D: N = 5 donors; 10–20 islets per donor; 505 cilia; Student’s two-tailed unpaired t test). ( C ) Number of cilia per area in islets from non-diabetic and type-2 diabetic islets (means ± SD; ND: n = 7 donors; T2D: n = 5 donors; Mann–Whitney U test). ( D ) Length of cilia with a swollen tip morphology in human islets from non-diabetic and typ-2 diabetic donors (means ± SD; ND: n = 6 donors; T2D: n = 5 donors; Mann–Whitney U test). ( E ) Length of cilia with rod-like morphology in human islets from non-diabetic and typ-2 diabetic donors (means ± SD; ND: n = 7 donors; T2D: n = 5 donors; Mann–Whitney U test). ( F ) Fraction of cilia with a swollen tip morphology in human islets from non-diabetic and typ-2 diabetic donors (means ± SD; ND: n = 7 donors; T2D: n = 5 donors; Mann–Whitney U test). ( G ) Correlation between cilium length and BMI in insulin-positive (Ins + , top) and insulin-negative (Ins-, bottom) cells in human islets from non-diabetic (black) and type-2 diabetic (red) donors (ND: n = 6 donors; T2D: n = 5 donors). ( H ) Correlation between cilium length and donor age in insulin-positive (Ins + , top) and insulin-negative (Ins-, bottom) cells in human islets from non-diabetic (black) and type-2 diabetic (red) donors (ND: n = 6 donors; T2D: n = 5 donors). ( I ) Primary cilia length in human islets cultured for 7 days in the absence (Ctrl) or presence (PA) of 0.5 mM palmitic acid (means ± SEM; Ctrl: 30 islets; PA: 22 islets; Student’s unpaired t test; 2 donors). ( J ) Confocal microscopy images of human islet from non-diabetic and type-2 diabetic donors immunostained against acetylated tubulin (green) and somatostatin (magenta). ( K ) Number of δ-cells per islet area (means ± SEM; ND: 31 islets, 3 donors; T2D: 32 islets, 2 donors; Student’s unpaired two-tailed t test). ( L ) Shortest distance between primary cilia and δ-cells (means ± SEM; ND: 31 islets, 3 donors; T2D: 32 islets, 2 donors; Student’s unpaired two-tailed t test). ( M ) Correlation between number of δ-cells and shortest distance between δ-cells and primary cilia (ND: 31 islets, 3 donors; T2D: 32 islets, 2 donors). ( N ) Confocal microscopy images of human islets from a non-diabetic and a type-2 diabetic donor immunostained against acetylated tubulin (magenta) and SSTR3 (yellow).
Article Snippet: The following primary antibodies were used in the study; acetylated tubulin (T745, host: mouse, 1:500; Sigma-Aldrich), Acetyl-α-Tubulin (K40) (5335, host: rabbit, 1:500; BioNordika),
Techniques: Confocal Microscopy, Two Tailed Test, MANN-WHITNEY, Cell Culture
Journal: The EMBO Journal
Article Title: Somatostatin triggers local cAMP and Ca 2+ signaling in primary cilia to modulate pancreatic β-cell function
doi: 10.1038/s44318-025-00383-7
Figure Lengend Snippet: ( A ) Confocal microscopy image of a mouse islet immunostained for somatostatin and acetylated tubulin. ( B ) Quantification of the number of cilia in close proximity to somatostatin-positive δ-cells and non-δ-cells in mouse islets (means ± SEM; n = 35; N = 7; P = 1.0E-5, Student’s paired t test). ( C ) Confocal microscopy images of mouse islets with transgenic expression of tdtomato in somatostatin-positive δ-cells and immunostained for acetylated tubulin to visualize cilia. ( D ) Quantification of the number of cilia in close proximity to tdtomato-positive or negative cells in mouse islets (means±SEM; n = 64; N = 10; P = 1.1E-12, Student’s paired t test). ( E ) Confocal microscopy image of a mouse islet with transgenic expression of tdtomato in δ-cells (magenta) immunostained for acetylated tubulin (cyan) and SSTR3 (yellow). Arrowheads show SSTR3-positive cilia. ( F ) Confocal microscopy images from two human islets immunostained against somatostatin (magenta), acetylated tubulin (cyan/green) and insulin (yellow). ( G ) Schematic cartoon of SST1.0 (left) and a confocal microscopy image (right) of a mouse islet expressing SST1.0. ( H ) Confocal microscopy image from a mouse islet with transgenic expression of both tdtomato (magenta) and SST1.0 (yellow) in δ-cells and immunostained against acetylated tubulin (cyan). ( I ) Confocal micrograph of a mouse islet with transgenic expression of tdtomato in δ-cells (magenta) and infected with adenovirus to express SST1.0 (green). Boxed region is magnified to the right. Traces are from cilia and cilia-adjacent plasma membrane regions and show SST1.0 fluorescence changes in response to 10 mM glucose. The regions corresponding to traces “C” and “PM” are indicated in the confocal micrograph. ( J ) SST1.0 fluorescence change in a mouse islet stimulated with 1 µM somatostatin. Traces are means ± SEM for 19 cilia and 17 cilia-adjacent plasma membrane regions. ( K ) SST1.0 fluorescence change in the cilium (magenta) and cilium-adjacent plasma membrane (black) within mouse islets exposed to 10 mM glucose (means ± SEM; N = 4 islets; n = 25 cells; two-tailed Student’s paired t test). ( L ) Frequency of SST1.0 fluorescence changes in the cilium (magenta) and cilium-adjacent plasma membrane (black) within mouse islets exposed to 10 mM glucose (means ± SEM; N = 4 islets; n = 25 cells; two-tailed Student’s paired t test). ( M ) Correlation between SST1.0 response amplitude in the plasma membrane (black) and cilium (magenta) and distance to nearest δ-cell. Notice that response amplitude is reduced with increased distance to δ-cells.
Article Snippet: The following primary antibodies were used in the study; acetylated tubulin (T745, host: mouse, 1:500; Sigma-Aldrich), Acetyl-α-Tubulin (K40) (5335, host: rabbit, 1:500; BioNordika),
Techniques: Confocal Microscopy, Transgenic Assay, Expressing, Infection, Clinical Proteomics, Membrane, Fluorescence, Two Tailed Test
Journal: The EMBO Journal
Article Title: Somatostatin triggers local cAMP and Ca 2+ signaling in primary cilia to modulate pancreatic β-cell function
doi: 10.1038/s44318-025-00383-7
Figure Lengend Snippet: ( A ) Confocal microscopy image of a primary cilium (acetylated tubulin; magenta) in a human islet that expresses SSTR5 (green). ( B ) Confocal microscopy image of primary cilia (acetylated tubulin; magenta) in a mouse islet that expresses SSTR5 (green). ( C ) Confocal microscopy image of a primary cilium (acetylated tubulin; magenta) in a MIN6 pseudoislet that lack expression of SSTR5 (green). ( D ) An illustration shows the membrane localization of SSTRs, with IC3 loop indicated by the purple box. Sequences of mSSTR2, mSSTR3 and mSSTR5. Conserved motif RxRxxR is highlighted. ( E ) Sequences of SSTR5 and SSTR3 showing the evolutionary conservation of a stretch of amino acids in purple.
Article Snippet: The following primary antibodies were used in the study; acetylated tubulin (T745, host: mouse, 1:500; Sigma-Aldrich), Acetyl-α-Tubulin (K40) (5335, host: rabbit, 1:500; BioNordika),
Techniques: Confocal Microscopy, Expressing, Membrane
Journal: The EMBO Journal
Article Title: Somatostatin triggers local cAMP and Ca 2+ signaling in primary cilia to modulate pancreatic β-cell function
doi: 10.1038/s44318-025-00383-7
Figure Lengend Snippet: ( A ) Representative TIRF microscopy recordings of cytosolic (black) and ciliary (magenta) FRET ratio changes in an islet cell expressing mArl13b-EpacS H188 following exposure to 1 µM forskolin and 100 nM somatostatin. ( B ) Means of ±SEM for the mArl13b-EpacS H188 FRET ratio change in mouse islet of cilia (magenta) and cytosol (black) in response to 1 μM forskolin, followed by the addition of 100 nM somatostatin. n cytosol = 23 cells, n cilia = 27 cilia, from three different animals. cilia basal-forskolin P = 0.00000024, cilia forskolin-SST P = 0.00000107, cytosol basal-forskolin P = 0.00000342, cytosol forskolin-SST P = 0.00000446; Sidak’s multiple comparison test. Bottom panel shows means ± SEM for the mArl13b-EpacS H188 FRET ratio change in MIN6 pseudoislet cilia (magenta) and cytosol (black) in response to 1 μM forskolin, followed by the addition of 100 nM somatostatin. n cytosol = 11 cells, n cilia = 18 cilia, from three different preparations. cilia basal-forskolin P = 0.000012, cilia forskolin-SST P = 0.000012, cytosol basal-forskolin P = 0.009468, cytosol forskolin-SST P = 0.013005, assessed with two-way ANOVA, Sidak’s multiple comparison test. ( C ) Means of ±SEM for the mArl13b-EpacS H188 FRET ratio change in MIN6 pseudoislet cilia (magenta) and cytosol (black) in response to TUG-891 (100 μM) followed by the addition of 100 nM somatostatin, and after addition of 10 μM forskolin. n cytosol = 33 cells, n cilia = 41 cilia, from three different preparations. Cilia; basal-TUG P = 0.0000002, TUG-SST P = 0.0000000000005, basal-forskolin P = 0.00002, cytosol; basal-TUG P = 0.0000009, TUG-SST P = 0.00000002, basal-forskolin P = 0.000007. Statistics was assessed with two-way ANOVA, Tukey’s multiple comparison test. ( D ) Quantitative RT-PCR determination of the relative reduction in SSTR3 mRNA following shRNA-mediated knockdown in MIN6 cells (six different experiments; Mann–Whitney U test). ( E ) Confocal microscopy images of primary cilia from MIN6 pseudoislets transfected with control (left) or SSTR3 (right) siRNA and immunostained against acetylated tubulin (green) and SSTR3 (magenta). The SSTR3 immunoreactivity in the cilium is quantified below (means ± SEM; n siCtrl = 83, n siSSTR3 = 86 cilia from three separate experiments; Mann–Whitney U test). ( F ) TIRF microscopy recordings of Arl13b-EpacS H188 FRET ratio in control (left) and SSTR3 KD (right) MIN6 pseudoislets exposed to 1 µM forskolin and 100 nM somatostatin. Magenta color indicates recordings from the cilium and black from the cell body (means ± SEM for 53 cells for control, 46 cells for knockdown). ( G ) Quantifications of the Arl13b-EpacS H188 FRET ratio from siSSTR3 transfected MIN6 pseudoislets in the presence of forskolin and somatostatin (normalized to pre-stimulatory level) (means ± SEM; 25 cilia-cytosol pairs for control and 22 cilia-cytosol pairs for knockdown. **** P = 0.000064; two-way ANOVA, Uncorrected Fisher´s LSD.). ( H ) Quantifications of the Arl13b-EpacS H188 FRET ratio following shRNA-mediated knockdown of SSTR3 in MIN6 pseudoislets exposed to forskolin and somatostatin (normalized to pre-stimulatory level) (means ± SEM; WT cilia = 50, WTcytosol = 44, KD cilia = 89, KD cytosol = 106. **** P = 0.000058; two-way ANOVA, Uncorrected Fisher´s LSD).
Article Snippet: The following primary antibodies were used in the study; acetylated tubulin (T745, host: mouse, 1:500; Sigma-Aldrich), Acetyl-α-Tubulin (K40) (5335, host: rabbit, 1:500; BioNordika),
Techniques: Microscopy, Expressing, Comparison, Quantitative RT-PCR, shRNA, Knockdown, MANN-WHITNEY, Confocal Microscopy, Transfection, Control
Journal: The EMBO Journal
Article Title: Somatostatin triggers local cAMP and Ca 2+ signaling in primary cilia to modulate pancreatic β-cell function
doi: 10.1038/s44318-025-00383-7
Figure Lengend Snippet: ( A ) Quantification of cytosolic area selected in MIN6 pseudoislets. Fluorescence intensity is from control (black) and SSTR3 KD (gray) cells immunostained for SSTR3. (means ± SEM; n ctrl = 50 and n K D = 48, 3 different preparations, no statistical difference by Mann–Whitney U test, unpaired.). ( B ) Quantifications of line profiles drawn along cilia of MIN6 pseudoislets for acetylated tubulin. Acetylated tubulin signal is unaffected on the left. (means ± SEM; n ctrl = 83 and n KD = 86, three different preparations, no statistical difference by Mann–hitney U test, unpaired.). ( C ) Quantifications of line profiles drawn along cilia of MIN6 pseudoislets positive for SSTR3. Ciliary SSTR3 signal is significantly reduced in shSSTR3 expressing cells (means ± SEM; n ctrl = 44 and n KD = 40 cilia, 1 preparation; Mann–Whitney U test, unpaired).
Article Snippet: The following primary antibodies were used in the study; acetylated tubulin (T745, host: mouse, 1:500; Sigma-Aldrich), Acetyl-α-Tubulin (K40) (5335, host: rabbit, 1:500; BioNordika),
Techniques: Fluorescence, Control, MANN-WHITNEY, Expressing
Journal: The EMBO Journal
Article Title: Somatostatin triggers local cAMP and Ca 2+ signaling in primary cilia to modulate pancreatic β-cell function
doi: 10.1038/s44318-025-00383-7
Figure Lengend Snippet: ( A ) TIRF microscopy image of a mouse islet expressing 5HT 6 -GGECO1. Traces below show the GGECO1 fluorescence change in cilia (magenta) and cytosol (green) in response to 100 nM somatostatin. ( B ) TIRF microscopy image of a MIN6 pseudoislet expressing 5HT 6 -GGECO1. Traces below show the GGECO1 fluorescence change in cilia (magenta) and cytosol (green) in response to 100 nM somatostatin. ( C ) Event count of all cilia Ca 2+ changes in mouse islet cells under resting conditions and following addition of 100 nM somatostatin (means ± SEM; n = 6 islets, 72 cilia; P = 0.0312 Wilcoxon test). ( D ) Event count of all cilia Ca 2+ flashes in MIN6 pseudoislet cells under resting conditions and following addition of 100 nM somatostatin (means ± SEM; n = 17 islets, 95 cilia; P = 0.0008 Wilcoxon test). ( E ) Event count of ciliary Ca 2+ changes of MIN6 pseudoislets following the addition of 100 nM somatostatin in control cells (black) and SSTR3 KD cells (magenta) (means ± SEM; n ctrl = 10 islets and 40 cilia, n KD = 11 islets and 30 cilia from three different preparations, P sictrl = 0.003, no change in siSSTR3, assessed by Sidak´s multiple comparison test). ( F ) Event count of all ciliary Ca 2+ changes in mouse islet cells that were either cultured under control condition or in the presence of pertussis toxin for 18 h and exposed to 100 nM somatostatin (means ± SEM; n ctrl = 6, 72 cilia, n PT = 7, 65 cilia; islets from four different preparations, SST response in control P = 0.0212, SST response in Pertussis-toxin treated islets not significant, assessed by Sidak´s multiple comparison). ( G ) Event count of ciliary Ca 2+ changes in mouse islet cells in response to 100 nM somatostatin, followed by the addition of 100 μM TUG-891. Means ± SEM for 25 cilia, from three different animals. *** P = 0.0004, ** P = 0.0021; two-way ANOVA, Dunn’s multiple comparison test. ( H ) Traces show the 5HT 6 -GGECO1 fluorescence change in cilia (purple) and cytosol (green) of mouse islet cells. Event count of ciliary Ca 2+ changes from mouse islet cells in response to 10 μM H89 are shown to the right (means ± SEM; 8 islets; 82 cilia; 3 different preparations. **** P = 0.000000001, Wilcoxon-matched pair t test). ( I ) Event count of ciliary Ca 2+ changes from mouse islets in response to 100 nM ghrelin (means ± SEM; 13 islets; 131 cilia from seven different preparations. *** P = 0.0008, Wilcoxon-matched pair t test). To the right is shown event count of ciliary Ca 2+ flashes from mouse islet in response to 100 nM ghrelin, followed by 100 nM SST (means ± SEM; 8 islets; 72 cilia from five different preparation. Dunn’s multiple comparisons test; basal-ghrelin P = 0.0035, basal-SST P = 0.0000000005, ghrelin-SST P = 0.0053). ( J ) Percentage of cilia in mouse islets that exhibit Ca 2+ changes in response to SST ( n = 72) or Ghrelin ( n = 46). ( K ) TIRF microscopy image of a mouse islet expressing 5HT 6 -GGECO1. Highlighted areas are: yellow and orange (δ-cells), green (β-cells), light purple (cilia close to δ-cells), purple (cilia far from δ-cells). ( L ) Ca 2+ concentration changes within the shaded areas in ( K ) in response to 100 nM ghrelin and 100 nM somatostatin. Scale bars: 5 µm.
Article Snippet: The following primary antibodies were used in the study; acetylated tubulin (T745, host: mouse, 1:500; Sigma-Aldrich), Acetyl-α-Tubulin (K40) (5335, host: rabbit, 1:500; BioNordika),
Techniques: Microscopy, Expressing, Fluorescence, Control, Comparison, Cell Culture, Concentration Assay
Journal: The EMBO Journal
Article Title: Somatostatin triggers local cAMP and Ca 2+ signaling in primary cilia to modulate pancreatic β-cell function
doi: 10.1038/s44318-025-00383-7
Figure Lengend Snippet: ( A ) Confocal microscopy images of mouse islets expressing Gli2-Halo JFX650 (yellow) and immunostained against acetylated tubulin (magenta) and insulin (cyan). Eighteen hours of treatment with 100 nM SAG or 100 nM SST induced translocation of Gli2 to the nucleus. ( B ) Fraction of β-cell nuclei positive for Gli2- Halo JFX650 in control mouse islets and in islets treated for 18 h with 100 nM SAG or 100 nM somatostatin (means ± SEM; n control = 34, n SAG = 40, n SST = 39 islets from two experiments; Student’s unpaired two-tailed t test). ( C ) Quantifications of cilia length (acetylated tubulin staining) from control (black), 18 h SST-treated (yellow) and 18 h SAG-treated (blue) mouse islet cells (means ± SEM; n ctrl = 111, n SST = 87, and n SAG = 105 cilia from two different preparations; Student’s unpaired two-tailed t test). ( D ) Quantifications of ciliary Ptch1 intensity from control (black), SST-treated (100 nM, 15 min; yellow) and SAG-treated (100 nM, 15 min; blue) mouse islet cells (means ± SEM; n = 79, 27 and 77 cilia; Student’s unpaired two-tailed t test). ( E ) Means ± SEM for the nucleus/cilia Gli2 ratio change in shSSTR3 transfected MIN6 cells following 18 h exposure to 100 nM somatostatin ( P ctrl =0.0418, P shSSTR3 > 0.999, assessed with Sidak´s multiple comparison test). ( F ) TIRF microscopy recordings of cilia Ca 2+ from mouse islets expressing 5HT 6 -GGECO1 and stimulated with 100 nM somatostatin. The islets were either cultured under control condition (black) or in the presence of somatostatin (purple) for 18 h followed by a 60 min recovery period. ( G ) Histogram showing ciliary Ca 2+ changes following 18 h incubation with (blue) or without (black) somatostatin followed by 30 min in the absence of somatostatin and acute re-application of 100 nM somatostatin ( n ctrl =16 cilia, n SST = 27 cilia; ciliary Ca 2+ changes response to SST is quantified; P Ctrl = 0.0016, P SST = 0.00011; Wilcoxon test). ( H ) Quantification of the effect of the effect of long-term somatostatin treatment on somatostatin-induced cilia Ca 2+ changes (means ± SEM; n ctrl = 3 islets, n SST = 4 islets). ( I ) Confocal image of a MIN6 cell expressing Gli2-GFP (green) and Arl13b-Parvalbumin (cyan) and immunostained against acetylated tubulin (magenta). Means ± SEM for the nucleus/cilia Gli2 ratio change in MIN6 cells expressing Arl13b-Parvalbumin and exposed to somatostatin for 18 h ( n ctrl =132, n SST = 132 cells from 4 independent experiments, Sidak´s multiple comparison test). ( J ) Changes in SSTR3 expression in MIN6 cells exposed to 100 nM somatostatin or 100 nM SAG for 18 h (means ± SEM; n = 2–3 experiments). ( K ) Changes in GLI2 expression in control or SSTR3 knockdown MIN6 cells exposed to 100 nM somatostatin or 100 nM SAG for 18 h (means ± SEM; n = 3–4 experiments; * P = 0.0376; Tukey´s multiple comparison test). ( L ) Changes in GLI3 expression in control or SSTR3 knockdown MIN6 cells exposed to 100 nM somatostatin or 100 nM SAG for 18 h (means ± SEM; n = 3–4 experiments; ** P = 0.0047; Tukey´s multiple comparison test). ( M ) Pseudo-colored TIRF microscopy images showing the increase cytosolic cAMP in response to 100 nM GLP-1 reported with EpacS H187 . Means ± SEM for the FRET ratio changes from MIN6 pseuodo-islets treated for 18 h with SAG (yellow), SST (purple) and SAG + SST (blue) are shown to the right (control-SAG P = 0.000008531, control-SST P = 0.000000004, control-SAG + SST P = 0.000002794; assessed by Dunn´s multiple comparison test; n ctrl = 143, n SAG = 161, n SST = 132 and n SAG+SST = 131 cells from three independent experiments). ( N , O ) Traces (means ± SEM) and scatter plot from EpacS H187 -expressing control or SSTR3 knockdown MIN6 pseudoislets exposed or not to somatostatin for 18 h, followed by acute stimulation with 100 nM GLP-1 (WT-WT_SST P < 0.000000000000001, WT_SST-KD_SST P = 0.0000002, WT-KD P = 0.00070; Sidak´s multiple comparison test; n WT = 240, n WT-SST = 200, n shSSTR3 = 259, n shSSTR3-SST = 148 from three different preparations). ( P ) A model of somatostatin signaling in the β-cell primary cilium.
Article Snippet: The following primary antibodies were used in the study; acetylated tubulin (T745, host: mouse, 1:500; Sigma-Aldrich), Acetyl-α-Tubulin (K40) (5335, host: rabbit, 1:500; BioNordika),
Techniques: Confocal Microscopy, Expressing, Translocation Assay, Control, Two Tailed Test, Staining, Transfection, Comparison, Microscopy, Cell Culture, Incubation, Knockdown
Journal: The EMBO Journal
Article Title: Somatostatin triggers local cAMP and Ca 2+ signaling in primary cilia to modulate pancreatic β-cell function
doi: 10.1038/s44318-025-00383-7
Figure Lengend Snippet: ( A ) Confocal microscopy images of MIN6 cells expressing Gli2-GFP (green) and immunostained against acetylated tubulin (magenta). 18 h treatment with 100 nM SAG and 100 nM SST induced translocation of Gli2 to the nucleus. ( B ) Means ± SEM for the nucleus/cilia Gli2 ratio change in MIN6 cells ( P SAG = 0.0345, P SST = 0.0266, P SAG+SST = 0.0186 all compared to control and assessed by Sidak´s multiple comparison test). ( C , D ) Islet averages ( C ) and example recordings ( D ) of glucose-induced R-GECO1 fluorescence changes in MIN6 pseudoislets treated for 18 h with DMSO (control), 100 nM SAG, 100 nM somatostatin or 100 nM SAG in combination with 100 nM somatostatin ( n = 3 replicates). ( E , F ) Islet averages ( E ) and example recordings ( F ) of glucose-induced R-GECO1 fluorescence changes in control and SSTR3 knockdown MIN6 pseudoislets treated for 18 h with DMSO (control) or 100 nM somatostatin ( n = 3 replicates).
Article Snippet: The following primary antibodies were used in the study; acetylated tubulin (T745, host: mouse, 1:500; Sigma-Aldrich), Acetyl-α-Tubulin (K40) (5335, host: rabbit, 1:500; BioNordika),
Techniques: Confocal Microscopy, Expressing, Translocation Assay, Control, Comparison, Fluorescence, Knockdown
Journal: The EMBO Journal
Article Title: Somatostatin triggers local cAMP and Ca 2+ signaling in primary cilia to modulate pancreatic β-cell function
doi: 10.1038/s44318-025-00383-7
Figure Lengend Snippet: Reagents and tools table
Article Snippet: The following primary antibodies were used in the study; acetylated tubulin (T745, host: mouse, 1:500; Sigma-Aldrich), Acetyl-α-Tubulin (K40) (5335, host: rabbit, 1:500; BioNordika),
Techniques: Recombinant, Plasmid Preparation, Sequencing, Virus, Cloning, Modification, Software, Microscopy, Real-time Polymerase Chain Reaction, SYBR Green Assay, Ligation
Journal: Endocrine-Related Cancer
Article Title: Neuroendocrine differentiation of prostate cancer leads to PSMA suppression
doi: 10.1530/erc-18-0226
Figure Lengend Snippet: Figure 3 Correlative analysis of FOLH1 with SSRT2 and NE genes. (A) The heatmap plot of the mean expression levels of FOLH1, NE genes and somatostatin receptor-2 gene (SSTR2) expression among patients of Cambridge dataset (Ross-Adams et al. 2015) (method to calculate distances is euclidean). (B) The percent of patients with suppression (Z-score ≤ +0.5), no alteration (−0.5 < Z-score < +0.5) and amplification (Z-score ≥ +0.5) of FOLH1 in each group of samples. (C) Pairwise correlation of treatment-induced gene expressions and Pearson correlation analysis from Cambridge dataset (Ross-Adams et al. 2015). (D) The expression of SSTR2 during progression of AdPC based on Gleason score from TCGA dataset generated by web-portal UALCAN (Chandrashekar et al. 2017). One-way ANOVA followed by a t-test was performed with Benjamini–Hochberg adjustment for multiple test correction; **P < 0.01 and ***P < 0.001, n.s.: no significant. (E) The comparison of SSTR2 expressions between AdPC and NEPC samples of Beltran dataset (Beltran et al. 2016) Error bars reflect s.e.m. and Student’s t-test was performed. A full-colour version of this figure is available at https://doi.org/10.1530/ ERC-18-0226.
Article Snippet:
Techniques: Expressing, Amplification, Generated, Comparison
Journal: Endocrine-Related Cancer
Article Title: Neuroendocrine differentiation of prostate cancer leads to PSMA suppression
doi: 10.1530/erc-18-0226
Figure Lengend Snippet: Figure 4 The probability of freedom from biochemical recurrence (BCR) of prostate cancer patients grouped according to the gene expression levels. Kaplan Meyer survival curves for high and low expression levels of (A) KLK3, (B) ENO2, (C) CHGA, (D) NCAM1, (E) SYP, (F) SRRM4, (G) REST, (H) SSTR2 genes generated by MSKCC (Taylor et al. 2010). A full-colour version of this figure is available at https://doi.org/10.1530/ERC-18-0226.
Article Snippet:
Techniques: Gene Expression, Expressing, Generated
Journal: Endocrine-Related Cancer
Article Title: Neuroendocrine differentiation of prostate cancer leads to PSMA suppression
doi: 10.1530/erc-18-0226
Figure Lengend Snippet: Figure 5 Analysis of PSMA and SSTR2 in a NEPC induced cell line. (A and B) Western blot analyses of protein level of PSMA, SSTR2, AR, NSE and p53 in 3 different prostate cancer cell line models. (A) Immunoblotting (B) diagram showing the relative density of protein levels. (C) Representative photos of control (left) and CSS-treated (right) LNCaP cells stained with Hoechst. Scale bar: 50 μm. (D, E and F) Neurites were studied under an inverted microscope: (D) % of cells with neurites counted over 3 fields of view over 3 separate experiments. (E) Neurites were measured using ImageJ software and longest neurite calculated. (F) Average neurite. (G, H, I, J, K and L) LNCaP cells are treated with either FBS or CSS as indicated and level of PSMA, SSTR2, AR, NSE and p53 were detected by (G and H) immunoblotting and (I, J and K) immunocytochemistry. (L) Data are quantified using ImageJ software. Stat: Error bars reflect
Article Snippet:
Techniques: Western Blot, Control, Staining, Inverted Microscopy, Software, Immunocytochemistry
Journal: Endocrine-Related Cancer
Article Title: Neuroendocrine differentiation of prostate cancer leads to PSMA suppression
doi: 10.1530/erc-18-0226
Figure Lengend Snippet: Figure 6 Analysis of treatment response to ENZ following a p53-dependent suppression of PSMA. (A and B) Western blot analyses of protein level of PSMA, SSTR2, AR and NSE in LNCaP cell line treated with vehicle control (DMSO) or ENZ (10 µM) supplemented with either FBS or CSS for 6 days (A) representative immunoblot (B) the relative density of protein levels. (C and D) Western blot analyses of protein level of PSMA, SSTR2, AR, NSE and p53 in LNCaP cell line transduced with annotated shRNA supplemented with CSS for 6 days. (C) Representative immunoblot (D) the relative density of protein levels. (E) Growth curve of LNCaP cell lines with different levels of PSMA following treatment with vehicle control (DMSO) or ENZ (10 µM) in supplemented with CSS. (F and G) The colony-forming ability of high-PSMA and low-PSMA seeded in 10% CSS for 1 week and treated with either ENZ (10 µM) or DMSO for one more week. (F) Representative wells (G) quantification of the number of the colonies using CellProfiler software. (H) Schematic of the impact of ARPI, hormonal deletion and loss of p53 on PSMA, AR and SSTR2 based on the obtained data in Figs 5 and 6. Error bars reflect s.e.m. between three separate experiments. The data were analyzed by either Student’s t-test or one-way ANOVA followed by a Tukey’s multiple comparison tests; **P < 0.01 and ***P < 0.001. A full-colour version of this figure is available at https://doi.org/10.1530/ERC-18-0226.
Article Snippet:
Techniques: Western Blot, Control, Transduction, shRNA, Software, Comparison